This course will provide an updated version of the NIDA and SAMHSA’s Blending Initiative product, originally entitled “Buprenophine Treatment: A Training for Multidisciplinary Professionals”. The primary goal of this training package is to create awareness among addiction professionals about medications currently approved by the FDA and used in the treatment of opioid dependence. The course includes information about what to expect when someone is treated with medication, information about the legislation that permits office based buprenorphine treatment, the science of addiction, the mechanism of each medication, patient selection criteria and associated patient counseling and therapeutic issues. OBJECTIVES: As a result of this training participants will: •Review the history of opioid treatment in the United States; •Discuss changes in the laws regarding treatment of opioid addiction and the implications for the treatment system; •Learn how medication will benefit the delivery of opioid treatment and the types of medications used to treat opioid use disorder; and •Possess knowledge about the demographics of people affected by opioid use disorder.